Linde PLC vs 22nd Century Group Inc — how do they compare? Linde PLC trades at $480.13 (market cap $226.12B), while 22nd Century Group Inc trades at $4.44 (market cap $1.52M). The key difference: Linde PLC is far larger — about 148763.2× 22nd Century Group Inc's market cap, and Linde PLC pays a 1.3% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| LIN | XXII | |
|---|---|---|
Market Cap | $226.12B | $1.52M |
Sector | Basic Materials | Technology |
52-Week High | $546.64 | $801.00 |
52-Week Low | $389.38 | $3.72 |
Enterprise Value | $249.24B | -$6.71M |
Dividend Yield | 1.3% | — |
Signals from Pluang's Aura AI — not financial advice
Linde (LIN) trades at $490.53, down 0.39% on the day, with a bearish technical signal from moving averages and overbought short-term RSI. The company shows strong fundamentals with Q1 2026 EPS of $4.33 beating estimates, 20.43% net income margin, and consistent revenue growth to $34.0B in 2025. Analysts are overwhelmingly bullish with a $553.60 consensus price target, supported by recent dividend payments and sustainability leadership recognition.
The outlook for LIN remains positive given robust profitability, earnings beats, and strong analyst support, though valuation multiples like a P/E of 31.65 suggest premium pricing. Key risks include rising debt-to-asset ratios and macroeconomic sensitivity, but the company's operational cash flow growth and strategic positioning in industrial gases underpin long-term potential for investors.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Trailing returns across standard periods
Latest headlines on both assets
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Read more on LIN →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →